Results 171 to 180 of about 7,239 (223)

Flap amputation for severe epithelial ingrowth post-LASIK: a case report. [PDF]

Int J Ophthalmol
Hosny M, Salem W.
europepmc   +1 more source

Cost-utility analysis of botulinum toxin type A versus oral drug treatment in patients with severe blepharospasm in Thailand. [PDF]

PLoS One
Hirunwiwatkul P, Permsuwan U, Ngamkiatphaisan S, Chirapapaisan N, Sriratanaban J.   +4 more
europepmc   +1 more source

Progressive Supranuclear Palsy (PSP): An Orthoptic Assessment. [PDF]

Br Ir Orthopt J
Burdon D, Mullin S, Harris C.
europepmc   +1 more source

Noninvasive transcranial brain stimulation for eye diseases and visual dysfunctions: A systematic review of RCTs. [PDF]

iScience
Zhang Q, Zhang H, Shi X, Li J, Wang C, Zhou H, Shan C.   +6 more
europepmc   +1 more source

Uveodermatological syndrome in dogs: A review of diagnosis, management, and ophthalmic patient needs. [PDF]

Vet Med (Praha)
Zubricky P, Balicka A, Drahovska Z, Lapsanska M, Trbolova A.   +4 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Blepharospasm and autoimmune diseases

Movement Disorders, 1987
AbstractWe studied two patients, one with systemic lupus erythematosus and the other with myasthenia gravis, both of whom had coexistent blepharospasm. The blepharospasm occurred during exacerbations of the autoimmune diseases and improved with immunosuppressive therapy.
Joseph Janković, Bernard M Patten
exaly   +3 more sources

Improvement of blepharospasm with Zolpidem

Movement Disorders, 2004
AbstractZolpidem (ZLP) is an imidazopyridine that binds to GABA receptors. We report on improvement of blepharospasm in 3 patients treated with ZLP. The GABAergic action of this drug on the output structures of the basal ganglia could explain the improvement of blepharospasm in these patients.
Nélida Susana, Garretto, José A, Bueri, Roberto D, Rey, Tomoko, Arakaki, Gabriela V, Nano, Marcela, Mancuso   +5 more
exaly   +3 more sources